MedTrace Logo

Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase.

NCT03689361 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-02-03

No results posted yet for this study

Summary

investigators hypothesize that T2 \* vein abnormalities are frequent and are specific to the migraine aura.

Conditions

  • Migraine Aura

Interventions

COMBINATION_PRODUCT

MRI

Routine MRI with all the sequences performed for the management of acute neurological deficit in the Toulouse Neuro Vascular Unit (diffusion, FLAIR, T2 \*, vascular sequences (AngioRM and TOF) and perfusion).

DIAGNOSTIC_TEST

MRI control

MRI with all the sequences performed for the management of acute neurological deficit in the Toulouse Neuro Vascular Unit (diffusion, FLAIR, T2 \*, vascular sequences (AngioRM and TOF) and perfusion)

OTHER

telephone consultation

telephone consultation

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Alain Viguier, PH · Uuniversity Hospital Toulouse

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-22
Primary Completion
2020-10-11
Completion
2020-12-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03689361 on ClinicalTrials.gov